Peer Review reports
From: The effects of lobbying on the FDA’s recall classification
Original Submission | ||
---|---|---|
7 Sep 2020 | Submitted | Original manuscript |
16 Nov 2020 | Reviewed | Reviewer Report |
11 Apr 2021 | Reviewed | Reviewer Report - Ken Bond |
15 Apr 2021 | Author responded | Author comments - Yifan Zhou |
Resubmission - Version 2 | ||
15 Apr 2021 | Submitted | Manuscript version 2 |
10 May 2021 | Reviewed | Reviewer Report |
14 May 2021 | Reviewed | Reviewer Report - Ken Bond |
1 Oct 2021 | Reviewed | Reviewer Report |
12 Oct 2021 | Author responded | Author comments - Yifan Zhou |
Resubmission - Version 3 | ||
12 Oct 2021 | Submitted | Manuscript version 3 |
23 Dec 2021 | Reviewed | Reviewer Report |
24 May 2022 | Author responded | Author comments - Yifan Zhou |
Resubmission - Version 4 | ||
24 May 2022 | Submitted | Manuscript version 4 |
6 Sep 2022 | Author responded | Author comments - Yifan Zhou |
Resubmission - Version 5 | ||
6 Sep 2022 | Submitted | Manuscript version 5 |
10 Oct 2022 | Author responded | Author comments - Yifan Zhou |
Resubmission - Version 6 | ||
10 Oct 2022 | Submitted | Manuscript version 6 |
3 Dec 2022 | Author responded | Author comments - Yifan Zhou |
Resubmission - Version 7 | ||
3 Dec 2022 | Submitted | Manuscript version 7 |
8 Dec 2022 | Author responded | Author comments - Yifan Zhou |
Resubmission - Version 8 | ||
8 Dec 2022 | Submitted | Manuscript version 8 |
3 Apr 2023 | Author responded | Author comments - Yifan Zhou |
Resubmission - Version 9 | ||
3 Apr 2023 | Submitted | Manuscript version 9 |
Publishing | ||
9 Jun 2023 | Editorially accepted | |
20 Jun 2023 | Article published | 10.1186/s12910-023-00921-0 |
You can find further information about peer review here.